The Dissemination/Outreach Program, including training and mentoring, aims at maximising the impact in terms of diffusion of knowledge beyond the consortium to the outside world, broadening the skills and knowledge of the researchers, and preparing the new generation of molecular imaging scientists to forward medical imaging in Europe.
Effective communication is ensured by (i) mandatory presence at 6-monthly meetings, (ii) provision of a password-protected collaborative workspace on the website, and (iii) regular use of emails and Skype between members of the consortium. The coordinator and partners have extensive experience in managing communication among network partners and the below list is also linked to the deliverables of the work package 9 (WP9).

Publications (D9.2) and scientific meetings
    Production of relevant articles and publications, in the area of biomaterials-based immodulation, molecular imaging of cells of the lymphoid and myeloid lineage, biomaterial MP and NP formats, vaccines and new immune competent models for studying tumour immunology. This addresses important themes of tumour immunology and immunotherapeutics in both the scientific and the industrial community. Furthermore, we also intend to work with Charles River, Jackson Laboratory and Taconic, all renowned for distributing different mouse strains to labs around the world, to write commercial brochures prior to distribution of the animal models generated from within our consortium. Papers will be co-authored by researchers from all partner institutions that contributed to the results. Whenever possible papers will be published in an open access journal. Meetings: will strongly encourage ESRs to present results at scientific conferences such as the European Association for Cancer (EACR), American Association for Cancer Research (AACR), or focussed meetings such as the Beatson International Cancer Conference, that of the International Society for Cancer Metabolism (ISCaM), or the European Society Molecular Imaging (ESMI) Meeting.
Two-way communication (linked to D9.4)
    Creating two-way communication channels with stakeholders, research communities, policy-makers, media and industry for disseminating the project achievements and results and ensure that the project results will remain in a commercial context after the project closure (thus assisting the exploitation of the project results).
Intranet and website (D9.1)
    Set up of the ISPIC project web, containing both a private part and public one. Public website:containing non-confidential project information, presentation of the training workshops, abstracts of presentation to conferences, published papers and newsletter.
Dissemination plan (D9.2)
    A dissemination plan is realized at the beginning of the project and is updated each year, covering the organisation of the dissemination actions, including policies, strategies and means. This plan constitutes the reference document for all dissemination activities.
Conference (D9.5)
    During M30 of the ISPIC project a network conference will be organised, in order to widespread the results of the project and to represent showcase of the achievements of the network. This conference will be open to scientists from other networks and from the wider scientific community. Our future ESRs will be encouraged to to present talks on how to become an ITN fellow, and how this impacts their research career, at meetings at the academic institutions.
Presentations on web portals (linked to D9.1)
    Presentation of the project on the web portals of partners (with link to the official web site). Dissemination of project results at conferences, workshops, seminars, European industrial group‟s meetings or exhibitions that will be organized during the project to which the ESRs will be kindly recommended to participate. Target events for disseminating ISPIC results are identified but there will be a broad focus on molecular imaging and tumour immunology.
Liaise with other like-minded networks
    The ISPIC network liaises with other like-minded networks, in order to enhance networking, learn from each other and compare best practice in general. This will include, for example, BrainPath (IAPP), PRISAR (RISE) and TargetCare (ITN), which are ongoing MARIE SKŁODOWSKA-CURIE grants funded under FP7 and H2020.
    All publications, presentations and communications are including an acknowledgement of this MARIE SKŁODOWSKA-CURIE ACTION.